Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B T Golding

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Chemical Research in Toxicology|October 20, 1998
A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adductsM J Tilby, H McCartney, K A Gould, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activityP G Smith, H D Thomas, H C Barlow, et al.
British Journal of Cancer|September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein bindingN J Curtin, K J Bowman, R N Turner, et al.
Chemical Research in Toxicology|December 22, 1998
Identification of novel metabolites of butadiene monoepoxide in rats and miceK A Richardson, M M Peters, R H Megens, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymeraseA W White, R Almassy, A H Calvert, et al.
British Journal of Cancer|October 27, 2005
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026B P Nutley, N F Smith, A Hayes, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP)H C Barlow, K J Bowman, N J Curtin, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanineR J Griffin, C E Arris, C Bleasdale, et al.
Journal of Medicinal Chemistry|August 24, 2000
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profilesC E Arris, F T Boyle, A H Calvert, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Chemical Research in Toxicology|October 20, 1998
A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adductsM J Tilby, H McCartney, K A Gould, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activityP G Smith, H D Thomas, H C Barlow, et al.
British Journal of Cancer|September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein bindingN J Curtin, K J Bowman, R N Turner, et al.
Chemical Research in Toxicology|December 22, 1998
Identification of novel metabolites of butadiene monoepoxide in rats and miceK A Richardson, M M Peters, R H Megens, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymeraseA W White, R Almassy, A H Calvert, et al.
British Journal of Cancer|October 27, 2005
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026B P Nutley, N F Smith, A Hayes, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP)H C Barlow, K J Bowman, N J Curtin, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanineR J Griffin, C E Arris, C Bleasdale, et al.
Journal of Medicinal Chemistry|August 24, 2000
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profilesC E Arris, F T Boyle, A H Calvert, et al.
Pageof 4